Streptococcus pneumoniae (pneumococcus) infections – pipeline

1. You can also request for sample page of above
mention reports on Customersupport@aarkstore.com

2. Price :
$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate Licence
Pages : 101

3. Summary
Global Markets Direct’s, Streptococcus Pneumoniae (Pneumococcus) Infections -
Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic
pipeline. This report provides information on the therapeutic development for
Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest
updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Streptococcus
Pneumoniae (Pneumococcus) Infections. Streptococcus Pneumoniae
(Pneumococcus) Infections - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary
databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry-
specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

4. Scope
- A snapshot of the global therapeutic scenario for Streptococcus Pneumoniae
(Pneumococcus) Infections.
- A review of the Streptococcus Pneumoniae (Pneumococcus) Infections products
under development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Streptococcus Pneumoniae (Pneumococcus) Infections.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

5. Table Of Contents
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Streptococcus Pneumoniae (Pneumococcus) Infections Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Streptococcus Pneumoniae
(Pneumococcus) Infections 10
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under
Development by Companies 12
Streptococcus Pneumoniae (Pneumococcus) Infections Therapeutics under
Investigation by Universities/Institutes 15
Late Stage Products 16
Comparative Analysis 16
Mid Clinical Stage Products 17
Comparative Analysis 17
Early Clinical Stage Products 18
Comparative Analysis 18
Discovery and Pre-Clinical Stage Products 19
Comparative Analysis 19…………………………..

6. More Related Reports:
http://www.aarkstore.com/publishers/pubreports.asp?PubId=4
9&pagenum=1
Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2
2012
H5N1 Infection (Avian Influenza) – Pipeline Review, H2 2012
Chemotherapy Induced Nausea and Vomiting – Pipeline Review, H2 2012
Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H2
2012
Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline
Review, H2 2012
Gastroesophageal (GE) Junction Carcinomas – Pipeline Review, H2 2012

7. For More details about above & other Reports
plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore